Real-World Study of the Effectiveness and Safety of Intracameral Bimatoprost Implant in a Clinical Setting in the United States.
Savak TeymoorianE Randy CravenLannhi NguyenErica WertsPublished in: Clinical ophthalmology (Auckland, N.Z.) (2024)
A single bimatoprost implant administration safely and effectively reduced IOP for up to 1 year and decreased the need for topical IOP-lowering medications in eyes with OAG or OHT with or without previous or subsequent SLT.
Keyphrases